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ABSTRACT
Throughout the world, research has been carried out in development of new methods
and materials involving multidisciplinary approach for effective bone tissue repair
and regeneration. Amid various biomaterials, bioactive glass material has drawn
considerable attention due to their superior biocompatibility, degradability, ion leaching
phenomena and propagation of osteogenic cells. In this concise review, effort has
been made to summarize different material combinations available as composition
to elaborate their biological properties both in vitro and in vivo, reaction kinetics in
simulated body fluid, effect of different constituents of bioactive glass and glass-
ceramic compositions, porosity, etc and finally these materials’ applications as bone
graft substitutes and various clinical applications have been detailed. In this review
an attempt has been made to sum up the recent advancement of different bioactive
glass and composite materials for osteoconductivity and osteoinductivity in
orthopaedic surgical challenges.
[Keywords: Bioactive glass, Bioglass®, Osteoconductivity, Osteoinductivity,
Hydroxycarbonate apatite, 45S5, S53P4, Bone graft]
Introduction
For effective bone tissue repair and regeneration
research has been carried out in designing of new
materials involving multidisciplinary approach. Numerous
scaffold systems for bone tissue engineering have been
introduced with novelty in scaffolds’ design, drug and
protein growth factors impregnation, mechanical strength
and neo bone forming ability, etc. Nonetheless, autograft
has still no alternative way for bone tissue repair. Autografts
fail to meet in general medical requirement for orthopaedic
implants. Alternative sources of allograft and xenograft are
detrimental as may cause disease transmission and
immune rejection. Accordingly, synthetic material plays a
crucial role to meet the vast demand, apart from its
limitations of strength, properties of osteoconduction,
osteoinduction, osseointegration and biodegradation. To
overcome such drawbacks, current research has been
paying attention on improvement of newer biomaterials,
enhanced alteration of structural and mechanical
properties, performance enhancement of biocompatibility,
osteoinductivity and addition of osteogenic cells onto
scaffolds to trigger bone renewal.
During bone healing, extracellular matrix (ECM)
containing collagen f ibre and mineralized calcium
phosphate is released from osteoblasts.1, 2 A biomaterial
scaffold having three-dimensional (3D) fibrous structure
mimicking the ECM is prerequisite for successful bone
regeneration in non load bearing defects.3–5 Moreover, the
scaffolds should not show any inf lammatory or
immunogenic reaction, be bioactive (ability to bond with
bone) and bioresorbable, permit new bone formation, be
cost effective, easily sterilizable, have optimal mechanical
properties6–9 and controllable interconnected porosity with
pore diameter of no less than 100 m (allow cells to grow
within pores and angiogenesis).10–12
In bone tissue engineering, a number of biomaterials
are presently being used as bone graft alternatives that
include bioceramics, magnesium phosphate, sulfate,
carbonate, calcium silicate and collagen. Some other
materials, like metal alloys (titanium, cobalt-chrome),
ceramics (zirconia, alumina), are also being used for the
same purpose, but having the drawbacks of resorbability
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interface. However, synthetic biodegradable polymers, like
polycaprolactone (PCL), polyethylene glycol (PEG) and
polylactic-co-glycolic acid (PLGA), show positive
interaction with cells without any deleterious effects in body
system.13, 14
Amid various biomaterials, bioactive glass material has
drawn considerable attention due to their superior
biocompatibility, degradability, ion leaching phenomena,
enhancing the adhesion and production of osteogenic
cells.15, 16 Mechanism of ion leaching includes exchange
of monovalent cations (Na+ or K+, with H3O+) from glass,
increase in pH of solution as a consequence which enables
osteoblast synthesis subsequently.17, 18 The macroporous
structure with large surface areas of bioactive glass favours
bone bonding.
Pores of bioactive glass are also advantageous for
resorption and bioactivity19 with nearly ten times more
strength than the contact osteogenesis.20 High modulus
and brittle nature limits its potential widespread application
and thus used widely as coating of metal implants which
forms calcium-deficient carbonated calcium phosphates
with time.
The aim of this review is to summarize the current
advancement of different bioactive glass and glass-
ceramic materials for osteoconductivity and
osteoinductivity in orthopaedic surgical challenges.
Bioactive Glass Materials
Prof. L. L. Hench discovered (in the year 1969) that
various compositions of glasses, when implanted to living
tissues, could bond chemically with bone.21–43 These
‘bioactive glasses’, since discovery, have mostly been used
as bone substitutes for repair of damaged tissues;31, 44
certain compositions of the same formed bond with soft
tissues and bone as well.40, 41, 45 Kinetic modification of
surfaces when implanted in vivo,26, 29 and formation of
hydroxycarbonate apatite (HCA) on top leading to bonding
at interface with tissues are some of very interesting
characteristics of these bioactive glasses. An interface is
developed between materials and tissues that oppose
considerable mechanical forces. Faster surface reaction
leads to faster bonding with living tissues, however, with
low mechanical properties.
To make the glass surface with enhanced surface
reactivity in contact with physiological fluids, high amounts
of CaO and Na2O are added (with relatively high
CaO/P2O5 ratio).46 Bioactive glasses with no Na or with
novel dopants have also been developed over last few
years which include f luorine,47 magnesium,48, 49
strontium,50–52 iron,53 silver,54–57 boron,58–61 potassium62 or
zinc.63, 64 Ag2O impregnated bioactive glass compositions
reduce microbials due to antimicrobial efficacy of Ag+
ions.56, 65 Texture of the matrix could be tailored by using
sol-gel method to obtain controlled Ag+ delivery. B2O3 in
CaO-SiO2 system enhances bioactivity due to presence
of more soluble boric compounds, leading to
supersaturation of Ca2+ ions of SBF (simulated body fluid)
and thus Si-OH groups of borosilicate glass helped apatite
formations as it acted as nucleation sites.66 Moreover, zinc
addition helps in better cell attachment by maintaining the
pH of SBF solution as well as causes osteoblast
proliferation. Figure 1 shows Na2O-CaO-P2O5-SiO2 glass
composition (constant 6 wt% of P2O5) dependence for hard
and soft-tissue bonding. Region A is the bioactive-bone
bonding boundary, composition of which forms bond with
bone. Region B (e.g. composition of those silica glasses
have applications including window, bottle or slides of
microscope) behaves almost inert and forms fibrous
morphology at implant-tissue interface. Region C
compositions are resorbable, which, within a day
disappears when implanted. Region D is not practical
technically and not tested in vivo. Collagen part of soft-
tissues usually adheres strongly in case of glass
compositions shown in region E (Fig. 1).
Fig. 1 – Na2O-CaO-P2O5-SiO2 based bioactive glass and glass-
ceramics compositions and their influence on hard and soft
tissue bonding; Region A has constant 6 wt% P2O5 composition,
soft tissue bonding at region E is inside dashed line with
bioactivity index (level of bioactivity of a material related to the
time with >50% of interface bonded) IB>8 [*: 45S5 Bioglass®,
: Ceravital®, : 55S4.3 Bioglass®, (....): soft-tissue bonding;
IB=100/t0.5bb, where t0.5bb is the time with more than 50% of implant










Melt-quench is still the most popular method to develop
bioactive glasses67–73 followed by sol-gel method.74, 75 In
the sol-gel method, metal-organic and metal-salt
precursors are used for sol preparation first, followed by
gel formation with time which includes completion of
reaction and/or aggregation and finally heat treatment with
stepwise drying, removal of organics and crystallization.76
It is a low temperature phenomenon for development of
porous glasses with high specific surface area.77 Recently,
both micron and nano-scale particles have been developed
as a part of this application57, 78, 79 including, combining
biodegradable polymers and bioactive glass.80–85 Bioactive
glass-ceramics having both osteoconduction and
osteoinduction properties are classified as Class A
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as Class B materials. Bioactive glass, if heated above its
crystallization temperature (610o-630oC), produces
bioactive glass-ceramics71, 78, 88, 89 and during the heating
process, parent glass shrinks, porosity reduces and
mechanical strength increases.87 However, bioactive
glasses are not being used presently as an alternative to
load-bearing implants owing to their limited strength and
low fracture toughness,44, 87, 88, 90 and thus, it still remains
an orthopaedic challenge.91, 92
Reaction Kinetics
Bioactive glass, when comes in contact with simulated
body fluid (SBF) or tris buffer saline (TBS), following
simultaneous reactions occur20, 46, 86, 93–95 (Fig. 2):
1) Exchange of H+ or H3O+ with alkali or alkaline earths
of glass network with interfacial pH typically more than
7.4.
2) Local release of silicic acid [Si(OH)4] by actions of
hydroxyl ions with -Si-O-Si-O-Si-. For glasses with
>60% silica content, dissolution rate decreases with
increase of bridging oxygens of such glasses.
Subsequently, there is structural rearrangements of
Si-OH by polycondensation and silica rich gel.
3) Formation and precipitation of amorphous calcium-
phosphate rich layer came from glass and solution and
further crystallization to carbonated hydroxyapatite
(HCA).
Hydrated silica actually helps for growth of HCA and it
is almost established that above reaction mechanisms are
neither dependent on presence of living tissues nor in vivo
conditions and can occur in contact with water as well.
However, subsequent bond with surrounding tissues
depends on the following:
1) Attachments of biological substance on HCA-SiO2 layer
2) Activity of macrophages or phagocytes
3) Stem cell attachment
Fig. 2 – Typical reaction kinetics for forming bond between bone and bioactive glass86, 95
4) Differentiation
5) Cell matrix formation and
6) Mineralization
To study the silicate glasses, which is considered to
be an inorganic silicon ‘polymer’ cross-linked by oxygen,
elucidation of network connectivity or cross-link density is
vital.96 Network connectivity refers average number of
additional cross-linking bonds (essentially more than two)
other than oxygen, which forms network anchor. This is
based on comparative number of network-forming oxides
(bridging oxygens) and network-modifiers (non-bridging
oxygens).97 The network connectivity of a glass can dictate
various physical properties including its solubility.98 Silicate
network formers with low network connectivity (low
molecular mass as well) are potentially bioactive owing to
their ease to go into solution and increased solubility.97
Glass properties have also been determined by
substitution of sodium oxide for calcium oxide.99  The basis
of bioactive glass systems should be mole per cent
substitutions than weight per cent when considered on a
structural level. Weight per cent basis may hide the
composition-property relationships of bioactive glass owing
to non-calculation of the degree of disruption of the glass
network.99, 100 In order to maintain same numbers of non-
bridging oxygen, one mole of NaO should be added if one
mole of CaO is removed from a highly disrupted glass
network to maintain same network connectivity value.
Wallace et al.97 used this concept for designing bioactive
glass compositions having controllable physico-chemical
and biological properties.
Fabrication
Different methods of fabrication and post heat-treatment
have important role on properties of bioactive glass and
glass-ceramics subsequently. Many researchers described
different fabrication methods including sugar or salt
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replication, temperature dependent phase separation, electro-
spinning, rapid prototyping, etc after optimizing structure,
properties and mechanical integrity of scaffolds,101, 102
textile and foam coating methods103–105 and biomimetic
approach.106, 107 Another area of research which is of
significance in bone-tissue engineering is mimicking the
nanostructure of natural bone by designing and incorporating
nano-topographic features on surface.72, 108–110 Many
researchers have also raised the scaffold manufacturing
procedure to a height.68, 70, 85, 105, 111, 112
Polymeric materials and foaming agents are added to
form the pores of bioactive glass and glass-ceramics.113
Rainer et al.114 used bioactive glass-loaded polyurethane
foam (in situ) for preparation of scaffolds of bone tissue
engineering. This method was found to be very suitable
for 3D processing and tailor-made applications in
reconstructive surgery. Lin et al.115 reported porous
bioactive glass-ceramics up to preclinical trial and used
polyethylene glycol (HO(C2H4O)-nH) with particle sizes
ranging between 5 and 500 m as foaming agent prior to
obtaining porous scaffolds. Due to uniform distribution of
porous channels (as seen from microstructures), better
bony in-growth and bioresorption of implants could be
seen. Similar type of porosity can be generated by addition
of organic polymers, e.g. dry/wet woods, crops (from food
processing and wood finishing)116 to completely degrade
at temperatures above 600oC and make the scaffold
porous. Apatite layers formed when bioactive glasses are
used in vitro / in vivo, also closely depend on variations of
texture properties (pore size, volume, structure) of
biomaterials. For example, owing to higher surface area
and pore volume, apatite formation and thus bioactive
behaviour were greatly enhanced.117
In the SiO2-Na2O-CaO-P2O5 glass system (like ordinary
soda-lime-silica glasses), certain percentages with
specific proportions of the compositions show bonding to
bone26, 31, 33, 37, 47, 61, 118–127 (Table I).
Bioactive Glass as Bone Graft Substitute
Bioactive glasses in the form of porous implants, fibers
and microspheres and being bioactive (interact with the
body) show both osteoconductive and osteoinductive
Sl. Name of the
No. bioactive glass SiO2 P2O5 CaO Ca(PO3)2 CaF2 MgO MgF2 Na2O K2O Al2O3 B2O3 Ta2O5/TiO2 ZnO
1. 45S5 Bioglass®31 45 6 24.5 – – – – 24.5 – – – – –
2. 45S5.4F Bioglass®31, 118 45 6 14.7 – 9.8 – – 24.5 – – – – –
3. 45B15S5 Bioglass®119, 120 30 6 24.5 – – – – 24.5 – – 15 – –
4. 52S4.6 Bioglass®121 52 6 21 – – – – 21 – – – – –
5. 55S4.3 Bioglass®121 55 6 19.5 – – – – 19.5 – – – – –
6. KGC Ceravital®26 46.2 – 20.2 25.5 – 2.9 – 4.8 0.4 – – – –
7. KGS Ceravital®26 46 – 33 16 – – – 5 – – – – –
8. KGy213 Ceravital®26 38 – 31 13.5 – – – 4 – 7 – 6.5 –
9. A/W glass-ceramics37 34.2 16.3 44.9 – 0.5 4.6 – – – – – – –
10. MB glass-ceramics33 19-52 4-24 9-3 – – 5-15 – 3-5 3-5 12-33 – – –
11. S45P7122 45 7 22 – – – – 24 – – 2 – –
12. S53P4123 53 4 20 – – – – 23 – – – – –
13. 13-93124 53 4 20 – – 5 – 6 12 – – – –
14. 4-Mar125 50.5 1 22.5 – – 6 – 5 15 – – – –
15. 18-04125 54.5 4 20 – – 4.5 – 15 – – 2 – –
16. 23-04125 56.25 1 20 – – 4.5 – 5 11.25 – 2 – –
17. H2-0261 53 2 22 – – 4.5 – 6 11 0.5 1 – –
18. CEL-247 45 3 26 – – 7 – 15 4 – – – –
19. 55S126 55 4 41 – – – – – – – – – –
20. H127 46.2 2.6 26.9 – – – – 24.3 – – – – –
21. HZ5127 44.4 2.5 25.9 – – – – 23.4 – – – – 3.8
22. HZ10127 42.5 2.4 4.8 – – – – 22.5 – – – – 7.8
23. HZ20127 38.8 2.2 22.6 – – – – 20.5 – – – – 15.9
Composition (%)
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properties.128 Bioactivity is mostly due to the SiO2 content;
presence of 45-52% SiO2 lift up the bonding of bioglass
with bone.129 The bioactivity and biocompatibility of
bioactive glass increase when it is combined with
hydroxyapatite130 and ultimately leads to increased
mechanical strength in comparison with calcium phosphate
when used alone. The mechanism behind that is a silicate-
rich layer is formed in contact with body fluids leading to
strong mechanical graft-bone bonding. That triggers
formation of hydroxyapatite layer. As a result new bone
formation accompanied by protein absorption occurs,
which, in turn, attracts mesenchymal stem cells,
macrophages and osteoprogenitor cells. Consequently,
osteoblasts are produced by dissemination of
osteoprogenitor cells into matrix.129, 131 Owing to sub-
optimal mechanical properties of bioactive glass, other
ceramic components are occasionally reinforced with the
bioactive glass. Alternate way to increase mechanical
strength and biological absorbability of SiO2-CaO bioactive
glass is incorporation of Na2O into bioactive glass by
sol-gel process, leading to formation of a hard yet
biodegradable crystalline phase when sintered.132 When
calcium concentration (GC5) is increased or P2O5 (GP2)
is decreased, mechanical properties of potassium
fluorrichterite (KNaCaMg5Si8O22F2) glass-ceramics are
improved. This can be used in development of medical
devices anticipated for bone tissue repair.133, 134 Foaming
with rice husks produces a new porous bioactive glass
(45S5) with sufficient mechanical support when sintered
at 1050oC for 1 h and can maintain bioactivity and
biodegrade at later stages.135
Greater filler effects of bioactive glass is observed in
comparison with autogenous bone in rat cancellous bone
defect models.136 Bioactive glass in conjunction with
allogenic demineralized bone matrix triggered bone
formation without any adverse cellular reaction.137–139 The
composite scaffolds comprising bioactive glass-collagen
alone and in combination with phosphatidylserine showed
greater biocompatibility and osteogenesis effects. The said
composites fulfilled the criteria to be used in bone tissue
engineering and proved itself to have tremendous
possibility in bone regeneration.140, 141 Incorporation of
mesenchymal stem cell with hyaluronic acid enhances
healing of the bone defect during scaffold preparation.142
Bone-bonding response is greatly enhanced by micro-
roughening of bioactive glass surface.143 Being
biocompatible it shows no inflammatory response in
tissues and resorption of glass fiber scaffolds are observed
within 6 months.144 Porous bioactive glass when used
experimentally in goat bone defect model, promoted new
bone formation that suggests its potential for orthopaedic
reconstructive procedures.145 Apart from its role in bone
tissue engineering, it has also beneficial role to enhance
neovascularization during soft tissue engineering of larger
size.146 Neovascularization is extremely essential
irrespective of hard and soft tissue healing which can be
accomplished by delivery of lower amount of bioactive
glass in site.147
Silica-based bioactive glasses are usually used for
dental restoration and bone implants and it also has the
ability to deliver drugs to site in conditions like bone
infections, defects, fractures (due to osteoporosis) and
tumours. Mesoporous silica micro-/nano-particles have
potentiality to be used as vehicle which can release anti-
cancer drugs within specif ic malignant cells.148, 149
Clinically, GTR (guided tissue regeneration) with collagen
membrane (CM) merged with autogenous bone, either as
graft or combined with bioactive glass, are compared and
concluded that autogenous bone can be mixed with
bioactive glass where there is less amount of harvested
bone. Jebahi et al.150 evaluated the performance of freeze
dried bioactive glass containing 17 wt%-chitosan
composite (BG-CH) in bone defects of ovariectomized rat
and found incorporation of 17 wt% CH with BG matrix to
significantly enhance the bioactivity and osteoinductive
property. Moreover, it increased Ca and P ion
concentrations in the implanted microenvironment.150, 151
Strontium ranelate has immense importance in the
treatment of osteoporosis, hence, incorporation of
bioactive strontium into mesoporous bioactive glass
scaffold enhances fracture repair process.152
Bioactive glass has inherent properties to be used as
scaffold materials; borate or borosilicate composition
induces new bone formation and doping with Cu, Zn or Sr
enhances healthy bone growth. Bioactive glass has
important role to enhance neovascularization and
neocartilage formation.153 Osteoconductive and
osteointegration properties of borate bioactive glass were
evaluated in rabbit model by synchrotron micro-CT, with
precise resolution, and resulted in detailed visualization
of biomaterial-bone assimilation and detailed
microarchitecture of both glass graft and newly formed
trabecular bone. Moreover, teicoplanin-loaded borate glass
showed osteoconduction.154
Bioactive glass in particulate form enhances bone
mineralization but may result in inflammation and particle
migration. Thus incorporation of chondroitin sulfate-(CS)
based bioadhesive improves amalgamation of the
bioactive glass as well as prevents particle migration,
promotes bone regeneration and provides mechanical
stability by encapsulating bone marrow.155 Modified (as
explained earlier) potassium f luorrichterite
(KNaCaMg5Si8O22F2) glass-ceramics gave direct bone
tissue contact in vivo through new bone formation and
cell proliferation along implant surface into medullary
space. But, inclusion of P2O5 improves osteoconductivity
and mechanical stability to a larger extent.156 6 mol% P2O5
containing bioactive glasses (SiO2-P2O5-CaO-Na2O-CaF2)
upon heat treatment, are crystallized to mixed sodium
calcium fluoride orthophosphates and fluorapatite which
have excellent properties of osteoconduction as well as
bone regeneration.157
Osteoinductive properties of the glass, on the other
hand, results due to dissolution products of glass (mainly,
soluble silica and calcium ions) which stimulates
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osteoblastic cells cultured on bioactive glasses, produce
collagenous extracellular matrix (ECM), which eventually
forms bone nodules without any supplementation and
absence of phosphate in the composition,158 whereas other
bioceramics need osteogenic supplements like
dexamethasone and b-glycerophosphate to be
incorporated.159–161 It also increases intracellular calcium
levels162, 163 and upregulate various gene. Calcium ions
and soluble silica from bioactive glass also help to
stimulate osteoblastic cell division, growth factors
production and ECM proteins.164
In vitro study shows that MSCs are differentiated into
osteoblasts and osteoclasts irrespective of presence or
absence of BMP-2 when cultured on bioactive sol-gel
coatings with low silica content (40 mol% SiO2, 54 mol%
CaO, 6 mol% P2O5),165 that accelerates osteogenesis and
remodelling. Whereas, MSCs differentiate only into
osteoblasts when cultured on glass coatings of high silica
content (80 mol% SiO2, 54 mol% CaO, 6 mol% P2O5). In
vitro culture of human adipose stem cells on bioactive
glasses show differentiation into osteogenic cells in
presence of osteogenic supplements.166
Studies with sol-gel derived elestrospun composite
fibrous membranes (using 45SiO2-24.5CaO-24.5Na2O6-
P2O5 and 43SiO2-24.5CaO-24.5Na2O6-P2O5-2Fe2O3
system pre-mixed with polyvinyl alcohol) revealed that the
magnetic particles embedded in the scaffolds have a
synergistic effect on osteoinductivity with and without
external magnetic field167 where magnetic particles play a
key role in providing osteoinductive properties to the
composite scaffolds.168
Clinical Applications
Bioactive glass coated screw was evaluated clinically
for Weber type B ankle fractures in 37 patients without
screw loosening within 2 years.169 Other clinical claim of
bioactive glass included vertebroplasty,170, 171 treatment
of unstable distal radius fracture,172 tympanoplastic
reconstruction,173 as filler in benign tumour surgery,136
facial bones reconstruction,174 management of periodontal
bone defects,175, 176 obliteration of frontal sinuses,177–179
repairing of orbital floor fractures,180, 181 lumbar fusion,182
reconstruction of maxillary sinus,183 cement-less
acetabular cups (with metal back-up)184 and restoration
of iliac crest defect post bone graft harvesting.185 The
allergenic mesenchymal stem cells can be delivered from
a thermoplastic, viscous carrier with a granular bioactive
glass scaffold in a clinically convenient form that was
proved to be efficient osteogenic substance during early
stages of canine alveolar repair.186
Bioactive glasses have also been used for spinal
fusion, coatings for orthopaedic metal implants,
replacement of bone, in dentistry (like periodontology and
endodontology), bone tissue engineered scaffolds,
composites and regenerative medicine.164, 187, 188 In clinical
dentistry, bioactive glasses (particles, porous or dense
scaffolds) have been used extensively.164
The composite product of bioactive glass-ceramics
A-W (apatite-wollastonite) and bioactive surface-modified
Ti-metal is used clinically as bone substitute (e.g. artificial
vertebrae and iliac crest) due to its better bone-bonding
ability and superior mechanical strength in contrast to
human cortical bone.189 Good osteoinduction, ectopic bone
formation occur in muscle when this porous Ti metal (after
strong acid treatment and post heat-treatment) was
used.190, 191 Likewise, heat treated porous Ti metal after
subsequent exposure to HCl treatment and NaOH
treatment also showed remarkable osteoinducion192  and
osteoconduction.193–195
Conclusions
During the past decades, biomedical materials have
shown a new vista for effective hard tissue and dental
repair as well as in local drug delivery systems. This has
enhanced life expectancy as well as meets the social
commitments for quality life. A considerable stride towards
the exploitation of synthetic biomaterials in bone and dental
tissue engineering has been explored. Amid various
biomaterials, bioactive glass has shown paramount
interest in clinical regenerative medicine due to its inducing
capacity as active biomineralization in vivo. Initially, it has
been thought for its efficacy in bone repair and restoration.
Of late, it has eventually become a very striking biomaterial
of  choice in various clinical settings like in dental,
maxillofacial and ear implants, soft tissue regeneration,
coating of metallic implants, drug delivery system, septic
wound dressing, growth factors carriers, bioactive
peptides, etc. In coming days, bioactive glass may be
utilized in a more befitting way by the scientists/
researchers/ clinicians for well being of human kind.
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